AstraZeneca PLC (AZN) Earnings: Quarterly Revenue, EPS and Margins
How are revenue and profit of AstraZeneca PLC developing? This page lists revenue, operating income, net income and earnings per share by quarter, taken from the company's published reports.
AstraZeneca PLC latest annual figures (FY 2025)
In the latest reported fiscal year (FY 2025), AstraZeneca PLC generated revenue of 58.74 USD bn. The largest segment is Oncology with 23.70 USD bn, about 40.3 % of total segment revenue. From gross margin (81.9 %) through operating margin (23.4 %) to net margin (17.4 %), the Sankey diagram shows how much of each revenue dollar remains at each stage of the income statement.
AstraZeneca PLC revenue by segment (FY 2025)
| Segment | Revenue | Share |
|---|---|---|
| Oncology | 23.70 USD bn | 40.3 % |
| Cardiovascular, Renal & Metabolism | 12.76 USD bn | 21.7 % |
| Respiratory & Immunology | 8.17 USD bn | 13.9 % |
| Vaccines & Immune Therapies | 846 USD m | 1.4 % |
| Rare Disease | 9.13 USD bn | 15.5 % |
| Other | 972 USD m | 1.7 % |
| Alliance Revenue | 3.07 USD bn | 5.2 % |
| Collaboration Revenue | 99 USD m | 0.2 % |
Frequently asked questions about AstraZeneca PLC
When does AstraZeneca PLC report earnings?
AstraZeneca PLC publishes quarterly results four times a year. The quarters listed on this page follow the company's fiscal calendar as reported in its filings.
What was AstraZeneca PLC revenue in the last fiscal year?
AstraZeneca PLC reported revenue of 58.74 USD bn (FY 2025).
How profitable is AstraZeneca PLC?
Net margin was 17.4 % (FY 2025), meaning that share of every revenue unit remained as profit.